$1.330
+0.031 (+2.31%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ALLO por análisis de gráficos similares
Alphio's ALLO stock price prediction model matches the current Allogene Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.32 (-1.02%). The 1-week path is $1.35 (+1.39%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Allogene Therapeutics, Inc.?
Allogene Therapeutics is not a good buy right now. The current price is $1.31, and the company has reported consistent losses, including a net income loss of $42,677,000 in Q2 2026. Additionally, the RSI is at 27.381, indicating that the stock is oversold, but this does not guarantee a price rebound. The main risk is the ongoing financial strain reflected in a negative forward P/E ratio of 0, suggesting that the company is not expected to generate profits in the near future.
ALLO cerró en $1.33 el Tuesday, tras subir +2.31%
Allogene Therapeutics, Inc. (ALLO) last closed at $1.33, gaining +2.31%. These facts feed the 1-day and 1-week ALLO price prediction above.
Consenso de analistas
Allogene Therapeutics, Inc. (ALLO): 3 comprar, 1 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Allogene Therapeutics, Inc. (ALLO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ALLO, ordenadas por similitud.
Análisis de estacionalidad de ALLO
Historically the probability of a positive October return for ALLO is 13.33%. February offers the highest probability of a positive month at 72.41%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.